Intralipid
Product Images NDC 51662-1333

Product Visual Gallery

This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Intralipid (NDC 51662-1333). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bag Labeling (Bag With Label)

INTRALIPID 20% 250 mL intravenous fat emulsion in a flexible plastic bag with dual ports. The label includes directions for intravenous use, ingredient amounts per 100 mL, storage instructions, a barcode, and manufacturer information. The product is labeled by HF Acquisition Co LLC, DBA HealthFirst.*

FDA Label Image

Desc 1 (Description Table 1)

Chemical structure diagrams of five fatty acids: Linoleic acid (C18H32O2), Oleic acid (C18H34O2), Palmitic acid (C16H32O2), α-Linolenic acid (C18H30O2), and Stearic acid (C18H36O2). Each structure illustrates the carbon (C), hydrogen (H), and oxygen (O) atoms and their bonds in the molecules.*

FDA Label Image

Desc 2 (Description Table 2)

Chemical structures of phosphatidylcholine and phosphatidylethanolamine are shown side by side in a table format, each labeled accordingly. The diagrams display molecular components and bonding relevant to these two compounds.*

FDA Label Image

Label (Label)

INTRALIPID 20% 250 mL label showing the product as a 20% intravenous (I.V.) fat emulsion. The label includes the NDC number 0338-0519-09 and states the volume as 250 mL. It indicates the product is for intravenous use and designated as prescription only. The labeler is HF Acquisition Co LLC, DBA HealthFirst.*

FDA Label Image

1 (Spl 1)

An instructional illustration showing a product bag with three labeled indicators below it. The text explains that the integrity indicator (Oxalert™) labeled 'A' should be checked before removing the overwrap, and if the indicator is black, the overwrap is damaged and the product should be discarded.*

FDA Label Image

2 (Spl 2)

An instructional illustration showing hands removing an overwrap from a container by tearing at a notch and pulling down. The image indicates the Oxalert sachet (A) and oxygen absorber (B) inside the packaging that should be discarded. The instructions suggest placing the bag on a clean, flat surface or hanging it on a support hook.*

FDA Label Image

3 (Spl 3)

An instructional illustration showing two types of infusion set spikes: non-vented and vented with a closed air vent. The accompanying text advises to use a non-vented infusion set or close the air vent on a vented set, follow infusion set instructions, use a spike with a diameter of 5.6 +/- 0.1 mm, and include a 1.2 micron filter in the infusion set while avoiding filters smaller than 1.2 microns.*

FDA Label Image

4 (Spl 4)

An instructional illustration showing hands breaking off the tamper-evident arrow flag from the blue infusion port of a container, demonstrating a step in the preparation or administration process for INTRALIPID by HF Acquisition Co LLC, DBA HealthFirst.*

FDA Label Image

5 (Spl 5)

An instructional illustration showing a hand holding the base of an infusion port and another hand inserting a spike straight through the center of the septum, accompanied by text emphasizing to insert the spike straight and not at an angle, and advising to inspect the bag and its contents for particulate matter before administration.*

FDA Label Image

6 (Spl 6)

An instructional illustration showing step 6 of a procedure involving an infusion bag. The image depicts a bag hanging from a hanger cut, with connectors at the bottom, indicating the next step to start the infusion process.*

FDA Label Image

Serialized Labeling (Serialized 51662 1333 1 Intralipid)

INTRALIPID 20% A 20% I.V. Fat Emulsion in a 250 mL flexible plastic bag with blue and white caps. The product is for intravenous use and is manufactured or distributed by HF Acquisition Co LLC, DBA HealthFirst. The label includes storage, usage instructions, and ingredient details including soybean oil, phospholipids, and glycerin. The product is sealed in a transparent overwrap bag.*

FDA Label Image

Stru 1 (Structure 1)

Chemical structure diagram depicting a triglyceride molecule with three fatty acid chains denoted as R1, R2, and R3 attached to a glycerol backbone, representing the active lipid component typically found in INTRALIPID products.*

FDA Label Image

Stru 2 (Structure 2)

Chemical structure diagram of a molecular component showing a carbon atom double bonded to oxygen (carbonyl group) labeled as R1C with additional atoms or groups extending, representing part of a chemical structure relevant to the product INTRALIPID.*

FDA Label Image

Stru 3 (Structure 3)

Chemical structure diagram showing a generic ester functional group with the notation R2C=O, likely representing a part of the active ingredient's molecular composition for the product INTRALIPID.*

FDA Label Image

Stru 4 (Structure 4)

Chemical structure diagram showing a partial molecular representation with a labeled group R3C indicating a carbonyl functional group. The image is a simplified structural formula fragment.*

FDA Label Image

Stru 5 (Structure 5)

Chemical structure diagram of the active ingredient for INTRALIPID by HF Acquisition Co LLC, DBA HealthFirst. The diagram shows a molecular structure with multiple carbonyl groups and ester linkages, representative of a lipid compound.*

FDA Label Image

Stru 6 (Structure 6)

Chemical structure diagram showing a partial molecular formula with a carbonyl group (indicated as R1C=O) representing a fragment of a molecule. The image focuses on a specific chemical moiety without additional labeling or elements.*

FDA Label Image

Stru 7 (Structure 7)

Chemical structure diagram showing a generic representation of an acyl carbonyl group labeled as R2C=O, indicating a part of a larger lipid molecule structure related to the product INTRALIPID.*

FDA Label Image

Stru 8 (Structure 8)

Chemical structure diagram showing a small molecular fragment with three carbon atoms and three hydroxyl groups, representing a chemical component related to the product INTRALIPID.*

FDA Label Image

Warnings (Warnings)

Text panel discussing risks related to intravenous fat emulsion use in preterm infants, including autopsy findings, the necessity of benefit-risk assessment, adherence to dosing guidelines, monitoring of triglycerides and free fatty acid levels, and considerations for administration in premature or low birth weight infants.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.